	Combined assessment of ERO1A expression and CD163(+) tumor-associated macrophage infiltration is superior to traditional assessment methods in predicting clear cell renal cell carcinoma prognosis. Front Oncol Hong T, Ren C, Xiang H, Wu H, Yu Y, Abudurexiti M, Wang Z, Wang C. PMID: 41809819 [PubMed]
	Identification of prognostic factors for postoperative recurrence-free survival in T2-stage renal cell carcinoma: a retrospective cohort study. Transl Androl Urol Wang Z, Qu R, Chen Y, An W, Li Y, He S, Wang W. PMID: 41809813 [PubMed]
	Development and validation of a biochemical recurrence risk assessment model for prostate cancer based on TCGA database. Transl Androl Urol Li M, Kang Y, Li J, Qi Q, Li M, Zhang A. PMID: 41809812 [PubMed]
	Derivation and validation of the SLNA score: a tumor size-location-number-apperance model to predict transurethral resection of bladder tumor (TURBT) complexity. Transl Androl Urol Zhang H, Zhang C, Xu J, Wang M, Sheng C, Xu Y, Zhu J, Zeng S, Xu C, Zhang Z. PMID: 41809805 [PubMed]
	Irreversible electroporation in prostate cancer: efficacy, tumor immune microenvironment remodeling, and combination immunotherapy-a narrative review. Transl Androl Urol Xiao J, Lv Z, Zhang Z, Wei H, Jiang X, Tian J. PMID: 41809804 [PubMed]
	The predictive value of multiparametric magnetic resonance imaging in enhancing prostate-specific antigen assessment for prostate cancer: a cross-sectional study. Transl Androl Urol Yu H, Wu J, Yang S. PMID: 41809802 [PubMed]
	Cathepsins in prostate cancer: multifunctional regulators in tumor progression and therapeutic prospects-a narrative review. Transl Androl Urol Zhu G, Yi X, Zhu B, Zou J, Zou X, Zhang G. PMID: 41809789 [PubMed]
	Diagnostic performance of transrectal ultrasound elastography integrated with clinical indicators in prostate cancer evaluation. Transl Androl Urol Dong XY, Zhou H, Sun JW, Yuan Y, Zhou XL. PMID: 41809779 [PubMed]
	Combined effect of diabetes and obesity on cancer risk in chronic kidney disease: a nationwide population-based study. Front Endocrinol (Lausanne) Kim CS, Suh SH, Choi HS, Bae EH, Ma SK, Jung JH, Kim B, Han KD, Kim SW. PMID: 41809530 [PubMed - in process]
	Ferroptosis: A Double-Edged Sword in Cisplatin-Based Cancer Therapy and Acute Kidney Injury. Cancer Manag Res Zhou S, Xiao Y, Fang L. PMID: 41809394 [PubMed]
	Impact of Surgical Wait Time on Survival After Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study. Cancer Manag Res Wang Q, Pei CS, Cao JY, Peng H, Niu W, Chang PA, Yao W, Zhang GH, Zhou J, Li SS, Wu JC, Wang H, Ju WB, Wang QC. PMID: 41809390 [PubMed]
	Artificial intelligence for prostate cancer detection and risk stratification using transrectal ultrasound: a narrative review. Gland Surg Zhang Q, Zhou C, Chen Y, Luo Y. PMID: 41808793 [PubMed]
	Artificial intelligence for detection, grading, and prognostication in prostate cancer pathology: A scoping review. Histol Histopathol Nair RP, Du W, Mei L, Koga S. PMID: 41808601 [PubMed - as supplied by publisher]
	Impact of PSMA PET/CT on Initial Staging and Planning of Definitive Radiation Therapy in Prostate Cancer. Br J Radiol Elsaka R, Hegazy H, Eldrieny A, Kotb M, Morsi M, Abdelaziz A. PMID: 41808439 [PubMed - as supplied by publisher]
	CSDE1 Drives Glycolysis and the Progression of Prostate Cancer Through RAC1-Dependent RAS/MAPK Activation. FASEB J Yin Z, Wang Z, Gong W, Wang Z, Li Z, Xu L, Ning J, Gao L, Pan T, Yu W, Zhou Y, Sun J, Cheng F. PMID: 41808419 [PubMed - in process]
	Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan. Int J Urol Abe T, Miyai K, Tsuzuki T, Murai S, Hashine K, Yamashita S, Kawahara T, Nishiyama N, Kitamura H, Kikuchi H, Saito K, Hibi H, Miyata H, Matsumoto R, Osawa T, Nishiyama H, Shinohara N. PMID: 41808310 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: HMGB1, an Autophagy-Associated Gene, as a Novel Noninvasive Diagnostic Biomarker-Clinicopathological Correlation in Urinary Bladder Carcinoma Patients. Ann Surg Oncol Data S, Trivedi S, Singh Y, Kumar U, Kumar L, Shankhwar SN, Srivastava A, Kumar A, Kar AG, Singh R, Zarekar R. PMID: 41807835 [PubMed - as supplied by publisher]
	Advances in artificial intelligence in prostate cancer pathology. Semin Diagn Pathol Chan GJ, Ding CC. PMID: 41807227 [PubMed - as supplied by publisher]
	Treatment Patterns Among Androgen Receptor Pathway Inhibitor-Experienced Patients With Metastatic Castration-Resistant Prostate Cancer: A Global Real-World Study. Clin Genitourin Cancer von Amsberg G, Bulkley A, DeCongelio M, Skiles G, Grisolano J, Yang L, Masurkar N, Morasso C, Costanza-McDonald S, Yin X, Teitsson S, Patel MY, Narayan V. PMID: 41807148 [PubMed - as supplied by publisher]
	Comparison of the Prostate Imaging After Focal Ablation (PI-FAB) and Transatlantic Recommendations for Prostate Gland Evaluation (TARGET) for the Detection of In-Field Prostate Cancer Recurrence on Post-Focal Therapy Prostate Magnetic Resonance Imaging (MRI). Clin Genitourin Cancer Zhu D, Malshy K, Cheng Z, Mali K, Shen M, Bandari J, Hollenberg GM, Weinberg EP, Frye TP. PMID: 41807146 [PubMed - as supplied by publisher]

Articles 1 - 20 / 176676

Page 1 of 8834



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy